Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus. It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer.
A vaccine against hepatitis B has been available since 1982. The vaccine is 95% effective in preventing infection and the development of chronic disease and liver cancer due to hepatitis B.
The hepatitis B virus can survive outside the body for at least 7 days. During this time, the virus can still cause infection if it enters the body of a person who is not protected by the vaccine. The incubation period of the hepatitis B virus is 75 days on average, but can vary from 30 to 180 days. The virus may be detected within 30 to 60 days after infection and can persist and develop into chronic hepatitis B.
In highly endemic areas, hepatitis B is most commonly spread from mother to child at birth (perinatal transmission), or through horizontal transmission (exposure to infected blood), especially from an infected child to an uninfected child during the first 5 years of life. The development of chronic infection is very common in infants infected from their mothers or before the age of 5 years.
Approx. Rs 5,000 / BottleGet Latest PriceProduct Details:
|Form Of Medicines||Tablets|
The newest drug that aims to fight against hepatitis B, which was licensed in India by Mylan pharma.
This generic drug is based on tenofovir alphanamide, the mechanism of action of which is completely identical to tenofovir, but a much greater effect is achieved when a small dose of the drug is administered - 10 times less than the dose of standard tenofovir.
What are the indications for the use of this medication?
This generic is necessary for the treatment of viral hepatitis B in individuals over 12 years old and weighing more than 35 kilograms. Moreover, it is used as one of the drugs in the complex therapy of this disease.
What are the main differences between the active substance and the usual tenofovir?
It is worth noting that a number of serious clinical studies have been carried out for people with viral hepatitis B. As a result, a marked decrease in the level of hepatitis B virus DNA was observed during therapy - less than 29 IU / milliliter.
What side effects are observed while taking this drug?
The same as during the reception of ordinary tenofovir, only with less negative effect.
HepBest is a highly effective agent for the treatment of viral hepatitis B
In any case, this generic is a real breakthrough in the treatment of viral hepatitis B, since the patient needs to take less medicine when achieving a higher effect in treatment.
The number of DNA cells decreases significantly as a result of taking this drug in a complex treatment.
It is worth noting that the company received the necessary license to launch production.
Keep the drug in a dry place, protected from sun and inaccessible to children, at a temperature of 15 to 30 ° C. Date of manufacture and shelf life are indicated on the packaging.
Approx. Rs 3,500 / BottleGet Latest PriceProduct Details:
|Drug Name||efavirenz, emtricitabine and tenofovir|
"Virarazer" is a combination of efavirenz, emtricitabine, and tenofovir, and is used to treat HIV. The combination of substances included in the drug significantly simplifies the schedule for the use of medications and helps patients to clearly observe the time of admission. In addition, the use of combined agents prevents the development of resistance (resistance) of the virus to certain substances. According to the testimonials available on the Virarazer tablets, this remedy significantly alleviates the condition of patients, prolonging their life.
Where can I buy Virarazer tablets?The described drug undoubtedly has a high efficiency, but, unfortunately, it is expensive. At tablets "Virarazer" the price in India is kept within 25,000 INR, which is really very expensive for patients who take antiretroviral therapy for years.
Explore More Products